Skip to product information
1 of 4

SKN Houston

Upneeq

Upneeq

Regular price $240.00
Regular price Sale price $240.00
Sale Sold out

Imagine an eye-opening lift with just one daily drop.

Upneeq ® is the only FDA-approved prescription eye drop for acquired ptosis (low-lying lids) that lifts your upper eyelids to open your eyes.

 

Skip the trip to the doctor’s office! Your online visit and prescription are included with your purchase if you are deemed a good candidate.

Directions: Apply one drop of Upneeq ® per eye, once a day. You’ll see a visible difference in as little as two hours. Many patients experience visible results as soon as 15 minutes after application!


INDICATION
UPNEEQ® (oxymetazoline hydrochloride ophthalmic solution), 0.1% is indicated for the treatment of acquired blepharoptosis in adults.
IMPORTANT SAFETY INFORMATION
WARNINGS AND PRECAUTIONS
  • Ptosis may be associated with neurologic or orbital diseases such as stroke and/or cerebral aneurysm, Horner syndrome, myasthenia gravis, external ophthalmoplegia, orbital infection and orbital masses. Consideration should be given to these conditions in the presence of ptosis with decreased levator muscle function and/or other neurologic signs.
  • Alpha-adrenergic agonists as a class may impact blood pressure. Advise UPNEEQ patients with cardiovascular disease, orthostatic hypotension, and/or uncontrolled hypertension or hypotension to seek medical care if their condition worsens.
  • Use UPNEEQ with caution in patients with cerebral or coronary insufficiency or Sjögren’s syndrome. Advise patients to seek medical care if signs and symptoms of potentiation of vascular insufficiency develop.
  • UPNEEQ may increase the risk of angle closure glaucoma in patients with untreated narrow-angle glaucoma. Advise patients to seek immediate medical care if signs and symptoms of acute narrow-angle glaucoma develop.
  • Patients should not touch the tip of the single patient-use container to their eye or to any surface, in order to avoid eye injury or contamination of the solution.
ADVERSE REACTIONS
Adverse reactions that occurred in 1-5% of subjects treated with UPNEEQ were punctate keratitis, conjunctival hyperemia, dry eye, blurred vision, instillation site pain, eye irritation and headache.
DRUG INTERACTIONS
  • Alpha-adrenergic agonists, as a class, may impact blood pressure. Caution in using drugs such as beta blockers, anti-hypertensives, and/or cardiac glycosides is advised. Caution should also be exercised in patients receiving alpha adrenergic receptor antagonists such as in the treatment of cardiovascular disease, or benign prostatic hypertrophy.
  • Caution is advised in patients taking monoamine oxidase inhibitors which can affect the metabolism and uptake of circulating amines.
To report SUSPECTED ADVERSE REACTIONS or product complaints, contact RVL Pharmaceuticals at 1-877-482-3788. You may also report SUSPECTED ADVERSE REACTIONS to the FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.
View full details

Don't forget to tag 

Image 1-2-24 at 6.10 AM 2.jpg__PID:be3d727f-c1b2-431b-b677-78c8801692ea
Image 1-2-24 at 6.16 AM.jpg__PID:78c88016-92ea-4167-ba07-e4cd52dfe491
Image 1-2-24 at 6.11 AM.jpg__PID:727fc1b2-a31b-4677-b8c8-801692ea7167
Image 1-2-24 at 6.09 AM.jpg__PID:70be3d72-7fc1-42a3-9bb6-7778c8801692
Broadband Providers

Quick Links

  • Gift Cards
  • Search
  • SKiN Policies
  • FAQ
  • Terms of Service
  • Privacy Policy

Open Hours

(346) 319 - 4803

1206 Hawthorne St.Houston, TX

  • Monday, 10 am - 2 pm
  • Tuesday-Friday, 9 am - 6 pm
  • Saturday, 9 am - 2 pm